Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment | Zendy

Valentina Lukashevich | Zendy; Anja Schweizer | Zendy; James E. Foley | Zendy; Dickinson | Zendy; PerHenrik Groop | Zendy; Wolfgang Kothny | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment

Author(s) -

Valentina Lukashevich,

Anja Schweizer,

James E. Foley,

Dickinson,

PerHenrik Groop,

Wolfgang Kothny

Publication year - 2013

Publication title -

vascular health and risk management

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.892

H-Index - 68

eISSN - 1178-2048

pISSN - 1176-6344

DOI - 10.2147/vhrm.s39300

Subject(s) - medicine , vildagliptin , type 2 diabetes , diabetes mellitus , insulin , endocrinology

The purpose of this study was to evaluate the efficacy of vildagliptin 50 mg once daily in patients with severe renal impairment (estimated glomerular filtration rate < 30 mL/min/1.73 m(2)) and longstanding type 2 diabetes not adequately controlled with insulin therapy, which is a difficult-to-treat population, with limited therapeutic options and a high susceptibility to hypoglycemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research